PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TMO vs. DHR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TMO and DHR is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

TMO vs. DHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Thermo Fisher Scientific Inc. (TMO) and Danaher Corporation (DHR). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
4.88%
-1.92%
TMO
DHR

Key characteristics

Sharpe Ratio

TMO:

0.20

DHR:

0.30

Sortino Ratio

TMO:

0.43

DHR:

0.60

Omega Ratio

TMO:

1.05

DHR:

1.07

Calmar Ratio

TMO:

0.17

DHR:

0.29

Martin Ratio

TMO:

0.51

DHR:

0.80

Ulcer Index

TMO:

7.94%

DHR:

8.27%

Daily Std Dev

TMO:

19.94%

DHR:

22.25%

Max Drawdown

TMO:

-71.16%

DHR:

-65.35%

Current Drawdown

TMO:

-15.48%

DHR:

-17.98%

Fundamentals

Market Cap

TMO:

$214.85B

DHR:

$174.72B

EPS

TMO:

$15.89

DHR:

$5.22

PE Ratio

TMO:

35.22

DHR:

45.66

PEG Ratio

TMO:

2.13

DHR:

3.18

Total Revenue (TTM)

TMO:

$31.48B

DHR:

$17.34B

Gross Profit (TTM)

TMO:

$12.89B

DHR:

$10.32B

EBITDA (TTM)

TMO:

$8.44B

DHR:

$5.33B

Returns By Period

In the year-to-date period, TMO achieves a 7.58% return, which is significantly higher than DHR's 3.84% return. Over the past 10 years, TMO has underperformed DHR with an annualized return of 16.53%, while DHR has yielded a comparatively higher 21.57% annualized return.


TMO

YTD

7.58%

1M

8.42%

6M

4.88%

1Y

3.08%

5Y*

10.83%

10Y*

16.53%

DHR

YTD

3.84%

1M

4.53%

6M

-1.92%

1Y

5.78%

5Y*

10.99%

10Y*

21.57%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TMO vs. DHR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMO
The Risk-Adjusted Performance Rank of TMO is 4949
Overall Rank
The Sharpe Ratio Rank of TMO is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of TMO is 4444
Sortino Ratio Rank
The Omega Ratio Rank of TMO is 4242
Omega Ratio Rank
The Calmar Ratio Rank of TMO is 5454
Calmar Ratio Rank
The Martin Ratio Rank of TMO is 5252
Martin Ratio Rank

DHR
The Risk-Adjusted Performance Rank of DHR is 5454
Overall Rank
The Sharpe Ratio Rank of DHR is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of DHR is 4949
Sortino Ratio Rank
The Omega Ratio Rank of DHR is 4747
Omega Ratio Rank
The Calmar Ratio Rank of DHR is 6060
Calmar Ratio Rank
The Martin Ratio Rank of DHR is 5656
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TMO vs. DHR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Thermo Fisher Scientific Inc. (TMO) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TMO, currently valued at 0.20, compared to the broader market-2.000.002.004.000.200.30
The chart of Sortino ratio for TMO, currently valued at 0.43, compared to the broader market-4.00-2.000.002.004.000.430.60
The chart of Omega ratio for TMO, currently valued at 1.05, compared to the broader market0.501.001.502.001.051.07
The chart of Calmar ratio for TMO, currently valued at 0.17, compared to the broader market0.002.004.006.000.170.29
The chart of Martin ratio for TMO, currently valued at 0.51, compared to the broader market-10.000.0010.0020.000.510.80
TMO
DHR

The current TMO Sharpe Ratio is 0.20, which is lower than the DHR Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of TMO and DHR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
0.20
0.30
TMO
DHR

Dividends

TMO vs. DHR - Dividend Comparison

TMO's dividend yield for the trailing twelve months is around 0.28%, less than DHR's 0.45% yield.


TTM20242023202220212020201920182017201620152014
TMO
Thermo Fisher Scientific Inc.
0.28%0.30%0.26%0.22%0.16%0.19%0.23%0.30%0.32%0.43%0.42%0.48%
DHR
Danaher Corporation
0.45%0.47%0.43%0.38%0.26%0.32%0.44%0.62%0.60%36.46%0.80%0.47%

Drawdowns

TMO vs. DHR - Drawdown Comparison

The maximum TMO drawdown since its inception was -71.16%, which is greater than DHR's maximum drawdown of -65.35%. Use the drawdown chart below to compare losses from any high point for TMO and DHR. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%AugustSeptemberOctoberNovemberDecember2025
-15.48%
-17.98%
TMO
DHR

Volatility

TMO vs. DHR - Volatility Comparison

Thermo Fisher Scientific Inc. (TMO) and Danaher Corporation (DHR) have volatilities of 5.29% and 5.28%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%AugustSeptemberOctoberNovemberDecember2025
5.29%
5.28%
TMO
DHR

Financials

TMO vs. DHR - Financials Comparison

This section allows you to compare key financial metrics between Thermo Fisher Scientific Inc. and Danaher Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab